PAO-CHU HSU: Open Payments
NPI 1790723849 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,819 in 90 payments from 18 companies in 2025. Trend: 2023 $1,170 · 2024 $1,510 · 2025 $1,819
Food & beverage: $1,819
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $322 |
| Novo Nordisk Inc | 16 | $316 |
| AstraZeneca Pharmaceuticals LP | 10 | $251 |
| Amgen Inc. | 14 | $159 |
| Dynavax Technologies Corporation | 6 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| Lilly USA, LLC | 6 | $108 |
| Exact Sciences Corporation | 5 | $101 |
| PFIZER INC. | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: AIRSUPRA, VRAYLAR, Heplisav-B, LEQVIO, MOUNJARO, Wegovy, Ozempic, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
